# Algenetix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/algenetix

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.algenetix.com
- Total disclosed funding: $2M
- Latest round: Series A (Apr 2, 2013)
- Investors on record: 1

## About

Algenetix is a domain name service provider focused on the biotech and renewable energy industries, specializing in premium domain acquisition and leasing.Algenetix operates as a premium domain name service provider, particularly catering to the biotech and renewable energy sectors. The company is headquartered in San Diego, US. In February 2016, ZeaKal acquired Algenetix, although financials were not disclosed. The latest funding round was a Series A amounting to USD 2.00 mn, with Finistere Ventures being the key investor. This funding represents the entirety of the total amount raised by the company, which also amounts to USD 2.00 mn.Algenetix specializes in offering premium domain names, particularly in the biotech and renewable energy sectors. Their core product, algenetix.com, reflects themes of "algae" and "genetics." The primary service involves domain acquisition, allowing clients to purchase or lease domains and facilitating a streamlined transfer process to registrars like GoDaddy and NameSilo. The company serves a varied clientele, including biotech firms, renewable energy startups, and software developers focused on genetic data analysis, with a global market reach.Algenetix generates revenue through the sale and lease of premium domain names, structured as direct purchases or lease-to-own agreements. Clients manage full DNS access immediately upon lease initiation, and the company charges for domain registrations with annual renewal fees typically ranging from USD 15 to USD 20 per year after the initial purchase. Their offerings also include professionally designed logos, enhancing value for clients in online branding, supporting both B2B and direct-to-consumer interactions.Algenetix plans to enhance its product line by developing additional premium domain names tailored specifically for emerging biotech innovations and renewable energy technologies. They aim to expand into international markets, particularly Europe and Asia, by 2025 in response to increasing global demand. The recent Series A funding of USD 2.00 mn will be utilized to support these initiatives, including product development and market entry strategies.

## Funding rounds

- Series A, Apr 2, 2013, $2M — Finistere Ventures

## Investors

- Finistere Ventures (https://capitalatlas.ai/funds/finistere-ventures) — Series A